Get started
Keyword

FEV1

Description: FEV1 is the volume of air a person can forcibly exhale during the first second of a spirometry test, used to assess lung function.
Wikidata ID: wiki/Q1309034
OpenAlex ID: keywords/fev1
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 · Philip H. Quanjer, Sanja Stanojevic, et al. · European Respiratory Journal · 5,929
PDF
Spirometric Reference Values from a Sample of the General U.S. Population
1999 · JOHN L. HANKINSON, JOHN R. ODENCRANTZ, et al. · American Journal of Respiratory and Critical Care Medicine · 4,206
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 · Bartolome R. Celli, Claudia G. Cote, et al. · New England Journal of Medicine · 4,027
PDF
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
1995 · Bartolomé R. Celli, Gordon L. Snider, et al. · 3,519
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
1999 · J C Bestall, E A Paul, et al. · Thorax · 2,923
PDF
Development of the asthma control test
2004 · Robert A Nathan, Christine A Sorkness, et al. · Journal of Allergy and Clinical Immunology · 2,902
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 · Bernard McCarthy, Dympna Casey, et al. · Cochrane Database of Systematic Reviews · 2,642
PDF
Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
2013 · Lutz Nährlich, Jochen G. Mainz, et al. · Cellular Physiology and Biochemistry · 2,525
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 · Hector G. Ortega, Mark C. Liu, et al. · New England Journal of Medicine · 2,325
PDF
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 · Bonnie W. Ramsey, Jane Davies, et al. · New England Journal of Medicine · 2,209
PDF
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 · Donald P. Tashkin, Bartolome Celli, et al. · New England Journal of Medicine · 2,193
PDF
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
2019 · Peter G. Middleton, Marcus A. Mall, et al. · New England Journal of Medicine · 2,184
PDF
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 · J J Soler-Cataluna · Thorax · 1,931
PDF
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
1983 · R J Knudson, M D Lebowitz, et al. · PubMed · 1,913
Bronchial reactivity to inhaled histamine: a method and clinical survey
1977 · D. W. COCKCROFT, D. N. KILLIAN, et al. · Clinical & Experimental Allergy · 1,840
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 · W Q Gan · Thorax · 1,838
PDF
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000 · P S Burge · BMJ · 1,675
PDF
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 · Henry J. Fuchs, Drucy S. Borowitz, et al. · New England Journal of Medicine · 1,539
PDF
Lebrikizumab Treatment in Adults with Asthma
2011 · Jonathan Corren, Robert F. Lemanske, et al. · New England Journal of Medicine · 1,524
The Effect of Air Pollution on Lung Development from 10 to 18 Years of Age
2004 · W. James Gauderman, Edward Avol, et al. · New England Journal of Medicine · 1,445
PDF
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
2016 · Eugene R Bleecker, J Mark FitzGerald, et al. · The Lancet · 1,412
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
2019 · Harry G M Heijerman, Edward F McKone, et al. · The Lancet · 1,404
PDF
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2016 · J Mark FitzGerald, Eugene R Bleecker, et al. · The Lancet · 1,399
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
2015 · Peter Lange, Bartolome Celli, et al. · New England Journal of Medicine · 1,285
PDF
A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma
1998 · Peter Lange, Jan Parner, et al. · New England Journal of Medicine · 1,254
Works count: 40,590
Citation count: 840,000
Year
Topic
Type